Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Travel Awards - Institute Community Support

University of Saskatchewan

$2,600.00

Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence

FY 2023-24

Summary
I started my first independent position in April 2021. It has been challenging to get up and running during the pandemic. I am looking forward to learning from my ECR colleagues and from senior PIs the secrets of running a successful lab. I am also looking forward to building my network and connecting with colleagues to create a support network for us ECRs, My laboratory studies highly pathogenic coronaviruses, such as MERS-CoV and SARS-CoV-2, and how these viruses negatively impact the human immune response. Specifically, we investigate virus replication using in vitro (cell lines and organoids) and in vivo models. We investigate innate immune responses in human cells upon infection with coronaviruses. We develop next generation vaccines and therapeutic that are broadly protective to prevent the emergence of novel coronaviruses with pandemic potential. My research falls under the mandates of CIHR's III.
Program
Travel Awards - Institute Community Support
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
491942
Name
Banerjee Arinjay
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Travel Awards - Institute Community Support
Projecttitle
Application for 2024 CIHR NIF (ECR): Investigating the role of SARS-CoV-2 and MERS-CoV transcription regulatory sequence (TRS) in viral gene expression and virulence
Programtype2
Undefined
Orgnameinp2
University of Saskatchewan
Cihramount2
$2,600
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Antiviral Immunity; Coronavirus; Ics Travel Awards; Mers-Cov; Sars-Cov-2; Viral Promoter
Abstract
I started my first independent position in April 2021. It has been challenging to get up and running during the pandemic. I am looking forward to learning from my ECR colleagues and from senior PIs the secrets of running a successful lab. I am also looking forward to building my network and connecting with colleagues to create a support network for us ECRs, My laboratory studies highly pathogenic coronaviruses, such as MERS-CoV and SARS-CoV-2, and how these viruses negatively impact the human immune response. Specifically, we investigate virus replication using in vitro (cell lines and organoids) and in vivo models. We investigate innate immune responses in human cells upon infection with coronaviruses. We develop next generation vaccines and therapeutic that are broadly protective to prevent the emergence of novel coronaviruses with pandemic potential. My research falls under the mandates of CIHR's III.
Competitiondate
202310
Approvedterm2
1 yr 0 mth
Pinamesdelim
Banerjee, Arinjay
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $2,600~ $0~
University of Saskatchewan - $2,600 Grant (2023-24) | Canada Spends